Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL

Blue Horseshoe Stocks: OSLH, PBR Updates & More

OSL Holdings, Inc. OSLH

OSLH is going to go down in the books as one of our hottest stock calls of the year following its epic run over the past couple of weeks.

We alerted this play on April 1st after it popped up on a scan the previous day. On April 2nd, we witnessed a low of .0021 in OSLH, and what happened next has been nothing short of astounding.

OSLH hit a high of .0274 during trading yesterday. It has accounted for an incredible 1294% rip in just ten sessions’ time. A big cheer goes out to anyone else who was able to get a piece of that rather large pie!

Petroleo Brasiliero S.A. (Petrobras) PBR

Like clockwork, PBR continued its impressive recovery from recent lows. The stock was trading at a low of 5.60 following our turning attention back to PBR back on 03/26. As of yesterday’s high of 8.90, the stock itself has rebounded a remarkable 59%

We’ve been consistently rolling up our strike prices as PBR has advanced on the charts. Our readers will recall that we mentioned our interest in Weekly In-the-money Calls, and anyone who entertained the $8 and $8.50 Weekly Calls as PBR pushed close to $9 this midweek, were in for some serious gain opportunities.

Yesterday alone, $8 Calls ran from .35-.87 (+148%), while the $8.50’s traded in a range from .13-.44 (+238%).

Molycorp, Inc. MCP

We’ve been tracking MCP of late, before yesterday, tagging the stock in our morning report from April 9th. Subsequent to that, we witnessed a low of .48 (04/13-04/14).

Yesterday brought a strong move from .68 to .96, which represents an intraday gain of 41%, and an overall increase of 100% over lows that were established just a couple of sessions back.

The stock is closing in on a dollar here in premarket trading, so we’ll need to keep an eye peeled, because MCP may yet have some ground to cover.

Voltari Corp. VLTC

VLTC has been another majorly successful recent call; we made this one along with OSLH in our Extended Watchlist back on April 1st. Subsequent to that, we observed a low of 2.18 and at yesterday’s high of 9.89 the stock had risen by 354%

Extended Watchlist:
MNOV, INVE, CLRX

Blue Horseshoe Stocks: Late Breaking News – PZOO

Pazoo, Inc. PZOO

Yesterday, PZOO continued its trend of producing healthy daily swings, While PZOO did dip briefly below the 50DMA early on, it gave us a chance at a respectable intraday gain, as it has already done several times in the past couple of weeks. The daily range carried the stock from a low of .0074 back up to the penny mark; a 35% move that came on greater than average volume.

We were recently updated on the status of Pazoo partner, MA & Associates, whose cannabis testing facilities still await the first shipments of product for testing. The State of Nevada has delayed the release of regulatory guidelines for growers pertaining to standardized levels of pesticides, pushing the expected date of first delivery to sometime in June. It does give newly appointed marketing and sales executive Michael Tulimero added time to position the company to secure an even larger presence with growers, who are undoubtedly anticipating the regulatory green light from the State as eagerly as anyone. >> READ PR

We want to take note of the significant PR that just hit the wires at 9:45am:

WHIPPANY, N.J., April 15, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that as of yesterday, the company has completely repaid the total of its obligations on its Convertible Promissory Notes to LG Capital Funding LLC and Macallan Partners LLC. In addition, Pazoo has given notice of its intention to fully pay off the Convertible Promissory Notes held by Union Capital LLC by the end of next week and Eastmore Capital LLC within the next two weeks. The total of the obligations, repaid and planned for the next two weeks, is approximately $400,000.

Pazoo as a company felt it extremely important to eliminate any conversions of these notes into free trading shares of the company’s common stock. With the tremendous strides recently attained through our 100% subsidiary, Harris Lee, LLC and 40% owned MA & Associates, LLC, Pazoo is currently working towards more traditional financing vehicles. This will also tremendously benefit the company as it will free up tens of millions of reserve shares for the company’s use. >> VIEW FULL PR

Extended Watchlist:
ANGI, CLSN, FOMX, MCP, OSLH, PBR

Blue Horseshoe Stocks: PBR & PZOO Updates

Petroleo Brasiliero, S.A. (Petrobras) PBR

Our repeated success with PBR has become so consistent that it borders on the comical. Even after providing us with cumulative percentage gains numbering in the thousands over the past couple of weeks, as we were mentioning in yesterday morning’s report, the stock still won’t quit.

Though our history of tracking PBR stretches back for well over a year now, we recently resumed keeping close watch over it starting on March 26th. The following day, as you’ll see on the chart snapshot below, it found support at 5.60, and from there it has quickly made quite a significant move. Yesterday’s high of 8.30 represents a 48% swing over a span of just over two weeks.

Ordinarily, we’d make a few annotations to highlight the finer points of a chart, but the major move and bullish characteristics are pretty obvious at a single glance. The stock has achieved higher highs and higher lows for 10 out of the last 11 sessions!

With the magnitude of the rebound we’re seeing from PBR, this play is going to occupy a large majority of our focus as we head into the middle of the week. As long as the stock continues to show strength, we’ll be looking to leverage the move to our advantage with Weekly In-the-money Calls.

We’re also going to be very interested to follow all the price action leading up to and directly following PBR’s earnings call, which as we learned very early this morning, is coming up on April 22nd.

Pazoo, Inc. PZOO

We also wanted to quickly touch upon PZOO once again this morning to highlight the news update provided by the company yesterday, specifically pertaining to its subsidiary MA & Associates, which is currently in the process of establishing its medical marijuana testing business in Nevada.

The PR alluded to the creation of MA & Associates Marketing and Sales Division, and the appointment of industry-veteran Michael A. Tulimero to head it up. Pazoo describes him as “a highly regarded, experienced sales executive in the Cannabis industry,” mentioning his role in representing his company at the Cannabis Cup conferences in L.A. and Amsterdam, which are sponsored by world-renowned High Times magazine.

From a chart standpoint, yesterday’s session marked the sixth in a row that it has registered a higher low. We’ll look for that trend to continue, however, on any pullbacks we’ll want to see PZOO hold support at or above its 50-day moving average of .008.

Blue Horseshoe Stocks: Reviewing Friday’s Session

Pazoo, Inc. PZOO

PZOO continued its recent pattern of offering up solid intraday gain opportunities with its performance on Friday. For some of our newest members- we refocused upon PZOO on April 1st. From that time up until Friday morning we’d seen positive intraday swings of 37% (04/01), 39% (04/06), 33% (04/07), 14% (04/08), and 40% (04/09).

On Friday, the stock presented another 15% swing as it traded in a range from .0087-.01. One thing we can definitely take away from these strong daily performances is that PZOO is building a heck of a chart. One look at the snapshot below and you can see just what we mean.

PZOO did a great job last week of bullishly registering a higher low each day, so we’ll be very interested to see how the chart reacts to start things off this week.  Ideally speaking, we want to see the stock maintain support at or above the 50DMA (.008) moving forward, and for it to make another run at penny-plus territory. We’ll be sure to keep our readers updated on the situation.

Frontline, Ltd. FRO

An old favorite of ours over the years, FRO was an inclusion in Friday’s extended watchlist, and it seems that we re-alerted this stock just in the nick of time.

The stock was able to open at and move up from a recent area of heavy resistance around the 2.40-mark, and from that low we saw a move to 2.67. While it amounts to just an 11% intraday gain, it held greater significance in that it is the first time FRO’s PPS exceeded its current 50DMA since the middle of February.

The move also paved the way for the stock to continue gapping up in this morning’s premarket, currently trading in the high 2.80’s. We’re definitely going to keep an eye peeled for this stock as we kick off a new trading week. Bullish indicators presently forming on the chart suggest that further chances to profit may be on the immediate horizon.

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

The PBR Options Chain has been a veritable gold mine for us over the past couple of weeks. We began with the $6 and $6.50 Calls the week before last, and as PBR continued to trend up we rolled our targeted strike prices up early last week to the Weekly and 05/01 $7 Calls, and all contracts concerned made appreciable moves, affording us the chance at percentage gains nearing the neighborhood of 1000%

Then on Friday, we did it again. We mentioned our interest in rolling our strike price up again to the 7.50-level, either in puts or calls depending on which way the trend wanted to carry the stock. It became quickly apparent that the bullish side would prevail, and we subsequently witnessed an intraday run from .09-.22. That’s a healthy rip totaling 144%

That calls for congratulations to anyone who has used PBR to leverage some hefty gains along with us of late; even as many on Wall Street have turned their backs on the Brazilian oil mega-producer.

We’ll continue to stay hot on its trail as long as it continues to serve us up premium chances, so stay tuned!

Get Our FREE Daily Reports!

SUBSCRIBE